Department of Neurosurgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, USA.
World Neurosurg. 2022 Dec;168:e297-e308. doi: 10.1016/j.wneu.2022.09.125. Epub 2022 Oct 2.
The purpose of this study is to retrospectively evaluate the clinical and surgical outcomes of a large surgical series of vestibular schwannoma from North America over 20 years.
After institutional review board approval a retrospective review of the senior author's personal case logs to identify patients who had operations for vestibular schwannoma was performed. The clinical notes, operative record, preoperative and postoperative imagings, and long-term clinical follow-up notes were evaluated.
A total of 415 patients who underwent 420 surgeries were identified from the years 1998-2021. The average length of follow-up was 3 years and 9 months. Overall, at last follow-up the rate of "good" facial nerve outcomes (House-Brackmann [HB] score I and II) was 86% and "poor" facial nerve outcomes (HB III-VI) was 14%. The amount of cerebellopontine angle extension (P = 0.023), tumor volume (P = 0.015), facial nerve consistency (P < 0.001), preoperative HB score (P < 0.001), and FN stimulation threshold at the end of the procedure (P < 0.001) were correlated to facial nerve function at the last follow-up.
This study represents one of the largest recently reported surgical series of vestibular schwannoma in North American literature with available long term follow-up. Facial nerve outcomes correlated with cerebellopontine angle extension, tumor volume, facial nerve stimulation threshold, facial nerve consistency, preoperative facial nerve function, and history of a prior resection. Tumor recurrence remains significantly higher after subtotal resection. We believe the data supports a continuation of a strategy of general intent of gross total resection, greatly modifiable by intraoperative findings and judgment.
本研究旨在回顾性评估北美 20 多年来大型听神经瘤手术系列的临床和手术结果。
在机构审查委员会批准后,对资深作者的个人病例记录进行回顾性审查,以确定接受听神经瘤手术的患者。评估临床记录、手术记录、术前和术后影像学以及长期临床随访记录。
从 1998 年至 2021 年,共确定了 415 例接受 420 次手术的患者。平均随访时间为 3 年 9 个月。总体而言,末次随访时面神经功能“良好”(House-Brackmann [HB] 评分 I 和 II)的比例为 86%,面神经功能“不良”(HB III-VI)的比例为 14%。小脑脑桥角延伸量(P=0.023)、肿瘤体积(P=0.015)、面神经一致性(P<0.001)、术前 HB 评分(P<0.001)和手术结束时 FN 刺激阈值(P<0.001)与末次随访时的面神经功能相关。
本研究是北美文献中最近报道的最大的听神经瘤手术系列之一,具有长期随访。面神经结果与小脑脑桥角延伸、肿瘤体积、面神经刺激阈值、面神经一致性、术前面神经功能和既往切除史相关。次全切除后肿瘤复发率仍然明显较高。我们认为,数据支持继续采用大体全切除的总体意图策略,该策略可根据术中发现和判断进行极大修改。